Sometimes a mammogram isn’t enough

What if you could do more to understand your risk of breast cancer? Myriad’s MyRisk® Hereditary Cancer Test can help identify hereditary cancer risks and empower you and your provider to take action for your health today and into the future.

Why is genetic testing important?

Hereditary cancer testing is a type of genetic test. It looks for genetic changes linked to a higher chance of developing certain cancers, like breast cancer. These genetic changes can be passed down in families. Hereditary cancer testing can give you and your healthcare provider important information to help manage your breast health.

Did you know?

1 in 4 women

in an OB/GYN setting meet criteria for hereditary cancer testing.1

1. DeFrancesco, et al. 2018

What is MyRisk with RiskScore?

MyRisk can help you and your provider understand your risk of developing 11 different types of cancer, including breast cancer. It can also provide important information for your family members if your test reveals a genetic change associated with hereditary cancer.

A more complete picture of cancer risk with RiskScore
For most patients, MyRisk test results also include RiskScore, a personalized estimate with five-year and remaining lifetime risk for developing breast cancer.

What happens after testing?

MyRisk test results are available ~two weeks after your blood or saliva sample is received at our lab. Watch this video to understand how it works, what your results could mean, and what comes next.

Watch video

Play Video

Access hereditary cancer resources

Connect with us for more information on hereditary cancer testing.

Sign up

Healthcare providers can order MyRisk for their patients.

Learn more

MyRisk Patient Story

Forging a Path Forward

Lisa’s mom’s battle with breast cancer inspired her to get genetic testing and make a life-saving choice. Her story is a testament to courage and resilience.

Related resources


SHE MD Podcast: Olivia Munn's Breast Cancer and the Test that Saved Her Life


What to Know About the Breast Cancer Risk Assessment Tool


Olivia Munn refers to Dr. Thaïs Aliabadi as her ‘guardian angel’


MyRisk affordability

Frequently asked questions

  • How much will this cost?

    Because we work with most major insurance companies, 9 out of 10 patients have no cost to them2. However, for those paying out of pocket, we provide cost estimates up front, so you know your costs before you commit. Financial assistance is also available to those who qualify. For further cost questions, visit our Costs & Process page.

    2. Based on internal Myriad data, 2023

  • Why does a doctor need to order this for me?

    Unlike recreational genetic tests, MyRisk® is a medical grade test that requires a healthcare provider’s signature to initiate testing. If you don’t have a healthcare provider or would prefer to test from the comfort of your home, consider our Virtual Care services which connect you to a genetic counselor who will help you to submit your test sample.

  • What are the potential outcomes of the test and their impact on me?

    Every results report is unique to the individual and provides an individualized risk estimate. Moreover, MyRisk produces personalized care plans that providers can use to help patients manage their risk. The plans can recommend a wide range of proactive options from risk reduction strategies to additional screenings.

  • Should I test with MyRisk if I have already had cancer?

    Hereditary cancer testing can give you and your healthcare provider necessary information to help manage your hereditary risk before the onset of cancer or before a second cancer has a chance to develop. Even if you have been diagnosed and treated in the past, MyRisk can still inform your future cancer risk.

    Testing could also be beneficial for discussing risks with your family members.

  • What is a Tyrer-Cuzick score? 

    Tyrer-Cuzick is a calculation used to estimate a person’s chance of developing breast cancer. It looks at your family history of cancer and other personal risk factors. If your chance of developing breast cancer in your lifetime is calculated to be 20% or greater, you may benefit from extra breast cancer screening. 

    If you take the MyRisk Test, a Tyrer-Cuzick score may be included. If your score is >20%, you'll be given a summary of medical care options to discuss with your healthcare providers.

  • Can the MyRisk team determine if I have cancer?

    MyRisk does not diagnose cancer. It is a test to evaluate your hereditary risk of developing 11 types of cancer. Myriad representatives are unable to provide medical advice or help diagnose any symptoms and recommend consulting with your healthcare provider.

  • When will I receive my results?

    Average turnaround time is within 14 days of sample submission.